MedPath

吉林省福尔泰药业有限公司

Ownership
-
Established
2015-12-04
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

41

NMPA:41

Drug Approvals

Compound Amantadine Hydrochloride Tablets

Product Name
复方金刚烷胺氨基比林片
Approval Number
国药准字H22025497
Approval Date
Sep 15, 2022
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H22025161
Approval Date
Mar 26, 2021
NMPA

Cefradine Capsules

Product Name
头孢拉定胶囊
Approval Number
国药准字H22025160
Approval Date
Mar 26, 2021
NMPA

Propranolol Hydrochloride Tablets

Product Name
盐酸普萘洛尔片
Approval Number
国药准字H22024713
Approval Date
May 22, 2020
NMPA

Vitamin C Pills

Product Name
维生素C丸
Approval Number
国药准字H22024805
Approval Date
May 22, 2020
NMPA

Troxerutin Tablets

Product Name
曲克芦丁片
Approval Number
国药准字H22025293
Approval Date
May 22, 2020
NMPA

Nitrofurantoin Enteric-coated Tablets

Product Name
呋喃妥因肠溶片
Approval Number
国药准字H22024813
Approval Date
May 22, 2020
NMPA

Vitamin B6 Tablets

Product Name
维生素B6片
Approval Number
国药准字H22024802
Approval Date
May 22, 2020
NMPA

Oral Five Vitamins and Glucose

Product Name
口服五维葡萄糖
Approval Number
国药准字H22024101
Approval Date
May 22, 2020
NMPA

复方茶碱麻黄碱片

Approval Number
国药准字H22026037
Approval Date
May 22, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.